Drawing for MEDI-SOLFEN

USPTO serial 79241986

MEDI-SOLFEN

Reviewed by CopyMark Law Group

Reg. 5905700Status 709
Filing date
Status date
Registration date
Nov 12, 2019
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDI-SOLFEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marcus N. DiBuduo

Marcus N. DiBuduo Fennemore Craig, P.C.8080 N. Palm Ave., Third FloorFresno, CA 93711UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; medical plasters; wound dressings; medical dressings; medical dressings impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; dressings for skin traumas; dressings for wounds; surgical dressings; surgical dressings being absorbable by the body; surgical dressings impregnated with substances to increase the rate of healing of the wounds in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; wound dressing substances, namely, wadding and gauzes; bandages impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; medicated cotton swabs; medical cotton swabs impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; medicinal and therapeutic preparations for the cleaning and debridement of wounds; medical and surgical antiseptic tissues; medical and surgical antiseptic wipes; medical and surgical antiseptic swabs; wound debridement products, namely, antibacterial sprays, washes, cleansers, gauzes, tissues, wipes, and swabs for medical purposes; materials for wound cleansing, namely, antibacterial sprays, washes, cleansers, gauzes, tissues, wipes, and swabs for medical purposes; materials for debridement, namely, antibacterial sprays, washes, cleansers, gauzes, tissues, wipes, and swabs for medical purposes; medical wound dressings for use in cleaning debris from wounds; cleansing pads for medical use; absorbent pads for medical use; medicated cleansing pads; medicated absorbent pads; medicated tissues and wipes; tissues and wipes impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; wound debridement pads; pads for wound cleansing; wound pads for medical use; dressings for wound bed preparation and cleansing; pharmaceutical preparations for pain relief, wound cleaning, wound sterilization, and wound healing; chemical preparations for pharmaceutical purposes, namely, for pain relief, wound cleaning, wound sterilization, and wound healing; chemical reagents for pharmaceutical purposes; chemical preparations for pharmaceutical purposes in the form of gels or sprays for pain relief, wound cleaning, wound sterilization, and wound healing; pain-relieving, wound-healing, and sterilising pharmaceutical preparations; topically applied pain-relieving, wound-healing, and sterilising pharmaceutical preparations; chemical preparations containing anaesthetics, local anaesthetics, analgesics, antiseptics or vasoconstrictors for pain relief, wound cleaning, wound sterilization, and wound healing; topically applied chemical preparations for pharmaceutical purposes containing anaesthetics, local anaesthetics, analgesics, antiseptics or vasoconstrictors for pain relief, wound cleaning, wound sterilization, and wound healing; topical pain-relieving gels and sprays; topical wound-healing gels and sprays; topical anaesthetic gels and sprays; topical analgesic gels and spray; topical antiseptic gels and sprays; anaesthetics; local anaesthetics; analgesic preparations; topical analgesics; topical anaesthetics; pharmaceutical preparations for skincare; pharmaceutical preparations for pain relief; topical gel, topical lotion and topically-applied spray for medical and therapeutic treatment of wounds; antiseptics; chemical preparations for pharmaceutical or medical purposes, namely, for treating wounds; pharmaceutical preparations containing anaesthetic agents, antiseptic agents and vasoconstrictors in the form of topically applied lotions, gels or sprays for treating woundsSECTION 71 - CANCELLED—
010Medical devices, apparatus and instruments for wound treatment and debridement; surgical devices, apparatus and instruments for wound treatment and debridementSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 29, 2026C71TCANCELLED SECTION 71—
Nov 12, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 13, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 13, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 18, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 30, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 20, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 4, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 3, 2020FIMPFINAL DISPOSITION PROCESSED—
Feb 12, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 12, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 27, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 23, 2019GPNXNOTIFICATION PROCESSED BY IB—
Aug 7, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 7, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 7, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 21, 2019ALIEASSIGNED TO LIE—
Jul 15, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jul 15, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 15, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 15, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 25, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 25, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 25, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 4, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 21, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 6, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 6, 2018RFRRREFUSAL PROCESSED BY MPU—
Nov 27, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 26, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2018DOCKASSIGNED TO EXAMINER—
Oct 13, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 4, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance